Ceftazidime: A Potent Third-Generation Cephalosporin Antibiotic

Discover the broad-spectrum power of Ceftazidime for tackling challenging bacterial infections with unparalleled efficacy.

Get a Quote & Sample

Key Advantages

Potent Against Resistant Bacteria

Ceftazidime's high stability against beta-lactamases allows it to combat bacteria that are resistant to other common antibiotics, including many Gram-negative strains.

Broad Spectrum of Action

Effectively targets a wide array of bacteria, offering a comprehensive solution for treating diverse bacterial infections, from respiratory to urinary systems.

Established Clinical Efficacy

With certifications like GMP and USP, Ceftazidime is a trusted pharmaceutical intermediate with proven results in treating serious bacterial infections.

Key Applications

Respiratory Tract Infections

Utilized in treating bacterial pneumonia and bronchitis, Ceftazidime combats the pathogens responsible for lung infections, including Pseudomonas aeruginosa.

Skin and Soft Tissue Infections

Effective for infections affecting the skin and underlying tissues, providing a reliable treatment option for bacterial compromised skin barriers.

Urinary Tract Infections

A critical antibiotic for treating complicated and uncomplicated UTIs, Ceftazidime helps eliminate bacterial invaders in the urinary system.

Meningitis and Sepsis

Its potent antibacterial properties make it essential for treating severe systemic infections like meningitis and sepsis, where rapid and effective action is crucial.

Why Choose Us?

Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.

Global Experience

With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.

Advanced Facilities

Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.

Seamless Scalability

We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).